Dr. Ellis of Baylor College of Medicine -  Presenting at 2016 MBC Conference


This activity is approved for AMA PRA Category 1 Credits™. 
 This activity is jointly provided by Baylor College of Medicine, Lester & Sue Smith Breast Center and Theresa’s Research Foundation


                                                                                                                                                                                Deadline for receipt of submissions is Monday, August 14, 2017 at 11:59PM CST. Abstracts will be peer-reviewed by the conference planning committee. 

   Travel Stipends are available for early career investigators who have a abstract accepted. Early career investigators include: graduate students, postdocs, and those who have not yet been tenured 

                                                                             Needs Statement

Metastatic breast cancer, Stage IV, or advanced breast cancer is the spread of cancer cells beyond the breast to new areas of the body, often by way of the lymph system or bloodstream. Metastases account for greater than 90% of cancer morbidity and mortality. In metastatic breast cancer this translates to nearly 40,000 deaths annually in the U.S. and more than 500,000 deaths worldwide. Metastatic breast cancer is the leading cause of cancer death in women below 50 years of age.

The Medical Conference will present updates on basic science, clinical, and survivorship issues that relate to the development, treatment, and sequelae of metastatic breast cancer. The integration of all three aspects is presented with the belief that collaboration across disciplines is required to understand and effectively treat disseminated disease.